Connor, Clark & Lunn Investment Management (CC&L)’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-10,025
| Closed | -$118K | – | 910 |
|
|
2017
Q3 | $118K | Sell |
10,025
-17,350
| -63% | -$204K | ﹤0.01% | 779 |
|
|
2017
Q2 | $287K | Sell |
27,375
-600
| -2% | -$6.29K | ﹤0.01% | 688 |
|
|
2017
Q1 | $308K | Buy |
27,975
+7,325
| +35% | +$80.6K | ﹤0.01% | 723 |
|
|
2016
Q4 | $280K | Sell |
20,650
-15,450
| -43% | -$209K | ﹤0.01% | 731 |
|
|
2016
Q3 | $444K | Buy |
36,100
+11,000
| +44% | +$135K | ﹤0.01% | 600 |
|
|
2016
Q2 | $275K | Buy |
+25,100
| New | +$275K | ﹤0.01% | 692 |
|